Award NoticeAwarded

Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza

HEALTH AND HUMAN SERVICES, DEPARTMENT OF · BARDA - ASPR / DAAPPO / BARDA DCMA

This notice records an award. Find active opportunities

Award Information

This solicitation resulted in an award to CIDARA THERAPEUTICS INC San Diego CA 92121 USA for approximately $339,189,481 on September 30, 2025. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Award Number: 75A50125C00017
Award Amount: $339,189,481
Award Date: September 30, 2025
Awardee: CIDARA THERAPEUTICS INC San Diego CA 92121 USA

View full award details on USASpending.gov

Contract Details

Notice ID: 75A50125C00017
Opportunity Type: Award Notice
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office: BARDA - ASPR / DAAPPO / BARDA DCMA
Posted Date: Tuesday, October 14, 2025
Response Deadline: Not specified
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC Code: AN13
Set-Aside: No Set Aside
Place of Performance: San Diego, CA, 92121, USA
Status: Awarded